Associate​/Senior Associate, Asset Acquisition

Description

Gondola Bio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as Bridge

BioX, a subsidiary of Bridge Bio, Gondola Bio secured $300M in private financing from external investors in 2024 and became an independent company within the Bridge Bio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, Gondola Bio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

Bridge Bio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at

The asset acquisition team finds and evaluates therapeutic ideas for Gondola Bio to pursue. The team works closely with members of Gondola Bio’s Investment Committee, which is composed of veteran drug developers and renowned academic scientists. As a key member of the team, this position will help set the culture and business development of the company and will be the face of the organization.

In particular, the duties of the Associate/Senior Associate will be to research, evaluate, and advocate for both particular investment opportunities and broader therapeutic areas for Gondola Bio to consider.

Requirements

• Deeply evaluate all aspects of a therapeutic program—from genetic rationale and pre-clinical evidence all the way to the development plan and clinical trial design
• Advocate for those that fit our goal of targeting the genetic source of a disease by building a scientific and business case for each potential investment
• Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs
• Lead internal discussions with management and the Investment Committee
• Establish a focused investment strategy and follow through to identify new investment opportunities
• Coordinate and work with a talented team of internal subject-matter experts—including clinical, commercial, and disease experts—to dive as deeply as needed for each project

No matter your role at Bridge Bio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

• A strong aptitude for and interest in science
• Excellent communication skills including the ability to express ideas concisely and cogently in writing and with Power Point
• An advanced technical degree; MD or Ph.D. is preferred
• Previous experience working at one of the following:
• Top tier consulting firm in the life sciences
• Venture…